Forget Snowflake: Buy These 2 Canadian IPOs Instead

Nuvei Corp. (TSX:NVEI) and another hot Canadian IPO that looks far cheaper than the recent Warren Buffett-baked Snowflake (NYSE:SNOW) IPO.

| More on:

The Snowflake IPO hype is nothing short of unprecedented. With Warren Buffett giving his stamp of approval on the white-hot new issues, many investors were lining up to get a piece of the tech sensation in spite of the recent September spike in volatility and weakness in tech stocks. As one of Buffett’s first forays into the IPO scene after decades of steering clear of such hype, there’s no question that the valuation on Snowflake has likely overshot to the upside. The new issue more than doubled on its trading debt.

As you may know, massive IPO busts tend to follow initial booms. And in the case of Snowflake stock, I think IPO investors late to the party could be dealt with amplified downside, especially given we’re in the midst of a tech-driven sell-off.

Like the Buffett of old, I’ve never been a huge fan of IPO investing because the risks of being caught holding the bag as just too high. I like to wait for the dust to settle on white-hot IPOs before considering initiating a position. As Snowflake falls back to Earth, patient investors may have a chance to get somewhat decent entry points into the Buffett-approved name. If you’re one of many investors who’s hungry to get your IPO fix right now, though, there are far better deals on this side of the border.

Nuvei

Canada’s IPO scene has been heating up lately, with digital payment processing play Nuvei (TSX:NVEI) landing on the TSX Index, rocketing over 55% in its debut. While Nuvei is no Snowflake, I do think it’s a far less dangerous IPO versus Snowflake, whose valuation is unfathomably expensive after one of the most impressive market debuts in recent memory.

Fellow Fool contributor Jed Lloren believes that Nuvei has millionaire-maker potential, but thinks investors should stick on the sidelines because of a potential IPO bust that could quickly follow its opening day boom. While I wouldn’t go as far as to call Nuvei a millionaire-maker (unless you put forth a massive six-figure principal), it’s a good idea for most beginner investors to wait for a better entry point, as this IPO season has been insanely hot, likely too hot for most to handle.

That said, fearless young investors keen on grabbing a hot IPO this season may want to consider nibbling on the way down, as the hype has a chance to die down amid this market-wide tech-driven correction.

Dye & Durham

Dye & Durham (TSX:DND) is another successful Canadian IPO that looks to be a far better value than the likes of a Snowflake. Shares recently plunged 17% amid the broader sell-off in growthy tech names. I view this pullback as a buying opportunity for growth investors looking to initiate a starter position.

For those unfamiliar with the name, it’s a cloud player that provides efficiency and productivity solutions for its growing base of clientele.

As I wrote in a prior piece, Dye & Durham was likely to follow in the footsteps of its value-adding cloud peers, as the firm looked to make a name for itself in its niche market.

“Many prospective clients will quickly realize over the years that Dye & Durham’s product is capable of saving considerable amounts of cash. Sooner or later, the platform may become indispensable for the players within the markets that Dye & Durham serves, much like Shopify is now a must for small businesses that need to get an online store up and running in the shortest amount of time possible.” I said in a prior piece.

What makes Dye & Durham sweeter than most other recent IPOs is its relatively modest 15.7 price-to-sales (P/S) multiple. Many cloud stocks sport P/S multiples in the clouds, above and beyond the 20x mark. I think DND stock deserves to trade in the middle of the pack and find it undervalued on a relative basis.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool recommends Snowflake Inc.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »